Medifast, Inc. (MED)
| Previous close | 24.43 |
| Open | 24.36 |
| Bid | 24.42 x 2200 |
| Ask | 24.50 x 900 |
| Day's range | 24.00 - 24.77 |
| 52-week range | 23.78 - 109.52 |
| Volume | |
| Avg. volume | 452,690 |
| Market cap | 267.524M |
| Beta (5Y monthly) | 1.21 |
| PE ratio (TTM) | 3.95 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 6.60 (27.02%) |
| Ex-dividend date | 18 Sept 2023 |
| 1y target est | N/A |
- Business Wire
Medifast Continues Business Transformation, Launching National Marketing Campaign Promoting its Holistic Offering for Customers Utilizing and Considering Weight Loss Medications
BALTIMORE, May 20, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and coach-guided lifestyle solution OPTAVIA®, today announced the launch of the first phase of its multimillion-dollar national marketing campaign. The campaign will highlight OPTAVIA’s new offering in collaboration with LifeMD®, the GLP-1 Lifestyle Program, a holistic approach to medical weight loss specifically tailored to support the needs of those utilizing GLP-1 medications. This robust
- Business Wire
Medifast Announces First Quarter 2024 Financial Results
BALTIMORE, April 29, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, today reported results for the first quarter ended March 31, 2024.
- Business Wire
Medifast to Announce Financial Results for the First Quarter Ended March 31, 2024
BALTIMORE, April 15, 2024--Medifast (NYSE: MED), the health and wellness company known for its habit-based and Coach-guided lifestyle solution, OPTAVIA®, will announce financial results for the first quarter ended March 31, 2024 on Monday, April 29, 2024, after market close. The Company will host a conference call to discuss the results with additional comments and details. Company participants will be Dan Chard, Chairman and Chief Executive Officer, and Jim Maloney, Chief Financial Officer.
